The following is a summary of “Trough levels of dalbavancin during long-term treatment of prosthetic joint infections,” published in the May 2025 issue of Infectious Diseases by Söderquist et al.
The post Monitoring Dalbavancin in Prosthetic Joint Infections first appeared on Physician’s Weekly.
